I'm a staff writer on Forbes' investing team, where I cover banks, asset managers and corporate mergers. I'm on the lookout for the next big thing being pitched on Wall Street and I like to tell the good, the bad and the ugly stories of deal making that investors ...
Teva Offers to Acquire Generic Drug Maker Mylan for $40 Billion
New York Times
Teva offers to buy Mylan for $40 billion